Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Water and extracellular matrix components refer to the non-cellular structural and fluid environment of tissues, most notably the ocular surface and the skin. In the context of pharmacology, these components serve as the primary therapeutic target for artificial tears, lubricants, and dermal fillers. Water provides the necessary hydration and osmotic balance, while extracellular matrix (ECM) components like mucins, glycosaminoglycans, and proteins provide structural integrity and lubrication. Drugs targeting these components, such as glycerin, polyethylene glycol, and hyaluronic acid, work by supplementing the natural fluid and matrix to alleviate conditions like dry eye syndrome and skin dehydration. These agents typically act through physical and osmotic mechanisms rather than binding to specific protein receptors. Additionally, emerging therapies like terahertz radiation are being explored for their ability to interact with water and ECM components to promote wound healing and tissue recovery.
Lubrication, osmotic hydration, stabilization of the tear film, and supplementation of the extracellular matrix.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Water and extracellular matrix components.